AbbVie (ABBV) call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics (APGE), FT reports
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $256.46 -1.44%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +9.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
Revenue Growth %: +9.7%
Join SI Premium – FREE
AbbVie (NYSE: ABBV) 30-day call option implied volatility 26; compared to its 52-week range of 18 to 36. Call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics, FT reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- ICICI Securities Reiterates Buy (1) Rating on Hindustan Unilever Ltd (HUVR:IN)
- ADARx Pharmaceuticals files for proposed IPO
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, Definitive Agreement, Maynard Um, Mark Zuckerberg, ARK, apgeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
